NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

"Mythic costs of drug R&D part of larger, dysfunctional system"

Posted By


Journalist Alison Bass writes about a new journal article that builds on the work of journalist Merrill Goozner and others in further dismantling the myth of high drug development costs.

Gooz’s book, “The $800 Million Pill: The Truth Behind The Cost of New Drugs,” is a classic.


You might also like

Comments (2)

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Susan Fitzgerald

February 22, 2011 at 12:35 pm

this is disturbing on so many levels, not least the corruption of academia by drug money. thank you for continuing to shine a light on the cost aspect of the medical industrial complex.